The Rise and Fall of Barry Investment Advisors' Q4 2022 vs. Q1 2023 Holdings

Barry Investment Advisors, LLC, recently filed its 13F for Q4 2022 and Q1 2023 with some interesting changes in its holdings. At first glance, it seems like the investment firm has made some significant gains, but a closer look at the numbers reveals a different story. In this blog post, we will analyze Barry Investment Advisors' 13F holdings and provide insights into the changes.

Firstly, let's examine the top gainers in Barry Investment Advisors' Q1 2023 compared to Q4 2022. VanEck ETF Trust (GDX) made the most significant leap with an increase of 46.9% in the number of shares held by the firm. This increase was accompanied by a rise of 47.1% in the fund's value. The success of GDX can be attributed to the global economy's instability, causing investors to shift their focus to gold as a safe haven.

Another top gainer was iShares Inc (IEV), which saw a massive increase of 67.7% in the number of shares held by Barry Investment Advisors. The fund's value also jumped by 67.0%, making it a significant contributor to the firm's gains. The growth can be attributed to the European market's strong performance, which the fund primarily invests in.

The third most substantial gainer was Sonos Inc (SONO). Although the number of shares held by the investment firm decreased by 37.5%, the value of the shares increased by 27.2%. SONO's growth can be attributed to the increased demand for smart speakers in remote work environments.

On the other hand, several funds saw a significant drop in Barry Investment Advisors' holdings. Pfizer Inc (PFE) was one of the worst performing funds, with a decrease of 19.4% in the number of shares held by the firm. This decrease was accompanied by a drop of 19.2% in the fund's value. The dismal performance can be attributed to the expiration of patents on some of Pfizer's leading drugs.

Similarly, Fidelity Covington Trust (FHLC) saw a decrease of 21.1% in the number of shares held by the firm, accompanied by a drop of 21.1% in the fund's value. The primary reason for this decrease was the significant disruption in the healthcare sector due to COVID-19.

Lastly, one of the most surprising moves was the addition of iShares Trust (IVV) with a holding value of $460,000. Although the number of shares held is negligible, the addition of the fund to the firm's portfolio shows an inclination towards the S&P 500 index fund.

In conclusion, Barry Investment Advisors' Q4 2022 vs. Q1 2023 13F holdings showed mixed results, with some notable winners and significant losers. The unexpected addition of IVV to the firm's portfolio is also an exciting development to look out for. It will be interesting to see how the investment firm's portfolio evolves in the coming quarters.